A comparison of Remdesivir versus gold cluster in COVID-19 animal model: A better therapeutic outcome of gold cluster. (June 2022)
- Record Type:
- Journal Article
- Title:
- A comparison of Remdesivir versus gold cluster in COVID-19 animal model: A better therapeutic outcome of gold cluster. (June 2022)
- Main Title:
- A comparison of Remdesivir versus gold cluster in COVID-19 animal model: A better therapeutic outcome of gold cluster
- Authors:
- He, Zhesheng
Ye, Fei
Zhang, Chunyu
Fan, Jiadong
Du, Zhongying
Zhao, Wencong
Yuan, Qing
Niu, Wenchao
Gao, Fuping
He, Bo
Cao, Peng
Zhao, Lina
Gao, Xuejiao
Gao, Xingfa
Sun, Bo
Dong, Yuhui
Zhao, Jincun
Qi, Jianxun
Liang, Xing-Jie
Jiang, Huaidong
Gong, Yong
Tan, Wenjie
Gao, Xueyun - Abstract:
- Abstract: While gold compound have been approved for Rheumatoid arthritis treatment as it well suppresses inflammatory cytokines of patients, no such treatment is currently available for COVID-19 treatment in vivo . We firstly disclose gold cluster yields better therapeutic outcome than Remdesivir in COVID-19 hamster treatments as it is armed with direct inhibition viral replication and intrinsic suppression inflammatory cytokines expression. Crystal data reveals that Au (I), released from gold cluster (GA), covalently binds thiolate of Cys145 of SARS-CoV-2 M pro . GA directly decreases SARS-CoV-2 viral replication and intrinsically down-regulates NFκB pathway therefore significantly inhibiting expression of inflammatory cytokines in cells. The inflammatory cytokines in GA-treated COVID-19 transgenic mice are found to be significantly lower than that of control mice. When COVID-19 golden hamsters are treated by GA, the lung inflammatory cytokines levels are significantly lower than that of Remdesivir. The pathological results show that GA treatment significantly reduce lung inflammatory injuries when compared to that of Remdesivir-treated COVID-19 hamsters. Graphical Abstract: ga1 Highlights: Au ions, released from gold cluster, specifically bind thiolate of Cys145 of SARS-CoV-2 M pro. Gold cluster inhibit SARS-CoV-2 M pro activity and SARS-CoV-2 replication. Lung injury of gold cluster-treated COVID-19 hamsters are significantly lower than that of Remdesivir-treatedAbstract: While gold compound have been approved for Rheumatoid arthritis treatment as it well suppresses inflammatory cytokines of patients, no such treatment is currently available for COVID-19 treatment in vivo . We firstly disclose gold cluster yields better therapeutic outcome than Remdesivir in COVID-19 hamster treatments as it is armed with direct inhibition viral replication and intrinsic suppression inflammatory cytokines expression. Crystal data reveals that Au (I), released from gold cluster (GA), covalently binds thiolate of Cys145 of SARS-CoV-2 M pro . GA directly decreases SARS-CoV-2 viral replication and intrinsically down-regulates NFκB pathway therefore significantly inhibiting expression of inflammatory cytokines in cells. The inflammatory cytokines in GA-treated COVID-19 transgenic mice are found to be significantly lower than that of control mice. When COVID-19 golden hamsters are treated by GA, the lung inflammatory cytokines levels are significantly lower than that of Remdesivir. The pathological results show that GA treatment significantly reduce lung inflammatory injuries when compared to that of Remdesivir-treated COVID-19 hamsters. Graphical Abstract: ga1 Highlights: Au ions, released from gold cluster, specifically bind thiolate of Cys145 of SARS-CoV-2 M pro. Gold cluster inhibit SARS-CoV-2 M pro activity and SARS-CoV-2 replication. Lung injury of gold cluster-treated COVID-19 hamsters are significantly lower than that of Remdesivir-treated COVID-19 hamsters. … (more)
- Is Part Of:
- Nano today. Volume 44(2022)
- Journal:
- Nano today
- Issue:
- Volume 44(2022)
- Issue Display:
- Volume 44, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 44
- Issue:
- 2022
- Issue Sort Value:
- 2022-0044-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-06
- Subjects:
- COVID-19 -- SARS-CoV-2 -- Gold cluster -- Viral replication -- Inflammatory cytokine
Nanotechnology -- Periodicals
Nanosciences -- Périodiques
620.505 - Journal URLs:
- http://www.sciencedirect.com/science/journal/17480132 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.nantod.2022.101468 ↗
- Languages:
- English
- ISSNs:
- 1748-0132
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6015.335517
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21797.xml